Symposium:
200. Clostridium difficile Infection in Children
Saturday, October 5, 2013: 2:00 PM-3:30 PM
Room: The Moscone Center: 103 (Gateway Ballroom)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the changing epidemiology of Clostridium difficile (C. difficile) infections in children
  • identify key bacterial and host factors important for the pathogenesis of C. difficile infections
  • outline and implement the options for treatment of routine and recalcitrant C. difficile infections in children

Target Audience: members-in-training, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Epidemiology and Infection Control

Moderators:  Patrick Seed, MD, PhD, Duke University and David Haslam, MD, Cincinnati Childrens Hospital Medical Center

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-086-L01-P

Disclosures:

P. Seed, None

D. Haslam, Pfizer-Washington University Biomedical Agreement: Grant Investigator, Grant recipient

D. Haslam, Pfizer-Washington University Biomedical Agreement: Grant Investigator, Grant recipient

P. Seed, None

E. Dubberke, Merk: Consultant and Investigator, Consulting fee and Research support
Viropharma : Investigator, Research support
Optimer: Consultant and Investigator, Consulting fee and Research support
Pfizer : Consultant, Consulting fee
Sanofi Pasteur: Investigator, Research support
bioMerieux: Consultant, Consulting fee

P. Toltzis, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.